Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Amexdrug Corporation

Market Cap 19.45M 16.94M 15.62M 14.69M 27.49M 1.83B 27.68M 186M 72.17M 903M 73M 71.43M 3.13B P/E 2011
168x
P/E 2012 103x
Enterprise Value 20.23M 17.62M 16.24M 15.28M 28.59M 1.91B 28.79M 193M 75.06M 939M 75.92M 74.29M 3.26B EV / Sales 2011
1.38x
EV / Sales 2012 1.01x
Free-Float
8.4%
Yield 2011 *
-
Yield 2012 -
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.41
10 years 0
Extreme 0.0001
1.12
Manager TitleAgeSince
Chief Executive Officer 66 2000-03-31
General Counsel - -
Director TitleAgeSince
Chairman 66 2000-03-31
Director/Board Member 76 2001-11-30
Director/Board Member 72 2001-11-30
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+100.00%-80.00% 33.82K
-3.74%-5.04%+3.62%+84.79% 91.3B
-1.99%+2.53%+34.48%+143.04% 53B
-0.53%+3.53%-14.04%+221.97% 22.85B
-1.24%-2.09%-10.72%-26.78% 8.05B
+2.31%-0.98%-32.36%-32.89% 7.19B
-2.73%-4.10%-10.98%-36.88% 6.71B
-0.52%-5.82%+12.99%+16.36% 6.31B
-1.54%-2.12%-3.15%+15.82% 5.3B
+1.47%+2.33%-6.58%-13.58% 3.51B
Average -0.89%-0.67%+7.33%+29.18% 20.42B
Weighted average by Cap. -2.38%+0.39%+7.28%+97.12%

Financials

2011 2012
Net sales 12.41M 10.81M 9.96M 9.37M 17.54M 1.17B 17.66M 119M 46.04M 576M 46.57M 45.57M 2B 9.15M 7.97M 7.35M 6.91M 12.93M 862M 13.02M 87.42M 33.95M 425M 34.34M 33.6M 1.47B
Net income 101K 87.69K 80.84K 76.04K 142K 9.49M 143K 962K 374K 4.67M 378K 370K 16.2M 82.03K 71.48K 65.89K 61.98K 116K 7.73M 117K 784K 304K 3.81M 308K 301K 13.21M
Net Debt 150K 131K 120K 113K 212K 14.14M 214K 1.43M 557K 6.97M 563K 551K 24.15M 778K 678K 625K 588K 1.1M 73.31M 1.11M 7.43M 2.89M 36.13M 2.92M 2.86M 125M
Logo Amexdrug Corporation
Amexdrug Corporation is a vertically integrated company, which is focused on healthcare and operating in the highly lucrative pharmaceutical, medical and cosmeceutical industry. The Company has eight business units, including Dermagen Inc., BioRx Pharma, BioRx Laboratories, Sponix Products, Royal Health Care, Amexhealth Plan and BioRx Labels. Dermagen Inc. manufactures pharmaceutical and skincare products, contract packaging and private labeling. BioRx Pharma unit is a manufacturer and distributor of pharmacy supplies, packaging and other health-care related products for pharmacy operations. BioRx Laboratories unit is a manufacturer and distributor of lab supplies and other related products for lab operations. BioRx Labels unit is a service provider of pharmacy labels. Sponix Products unit is health and wellness products for total health care. Royal Health Care develops and distributes nutraceuticals, nutritional supplements, vitamins and all-natural skincare products.
Employees
11
  1. Stock Market
  2. Stocks
  3. AXRX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!